Question: CRISPR-Cas9 delivery methods for in vivo therapeutic editing

FDA guidance on CRISPR therapeutic delivery safety

Needs new evidence

1/2 publication-ready

2 verified (technical)

Findings metrics

—

total

—

verified

—

pending

—

rejected